Roche and bluebird bio settle year-long trademark case, but keep quiet on the details

Bluebird and Roche’s Spark Therapeutics together filed a motion this week to dismiss a trademark infringement suit over the former’s “Be the Spark” sickle cell campaign. That’s all the information they’re sharing for now, as a bluebird spokesperson told Endpoints News that the details of the settlement agreement remain confidential.